CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-18 | Galante Joseph C Director | Grant or award | +1,800 | $2.80 | $5K | 63,656 |
| 2026-03-18 | Herman James L VP and Chief Compliance Office | Grant or award · Options (right to buy) | +2,500 | $2.80 | $7K | 21,000 |
| 2026-03-18 | Brown Martin S JR Director | Grant or award | +1,800 | $2.80 | $5K | 10,300 |
| 2026-03-18 | Jones James Director | Grant or award | +1,800 | $2.80 | $5K | 46,863 |
| 2026-03-18 | Krogulski Kenneth Director | Grant or award | +1,800 | $2.80 | $5K | 298,338 |
| 2026-03-18 | Krogulski Kenneth Director | Grant or award | +4,000 | $2.80 | $11K | 302,338 |
| 2026-03-18 | Young Caroline Director | Grant or award | +1,800 | $2.80 | $5K | 35,109 |
| 2026-03-18 | Anthony Todd M. Vice Pres Organizational Dev | Grant or award · Options (right to buy) | +3,000 | $2.80 | $8K | 21,000 |
| 2026-03-18 | Bitterman Chris T. Vice Pres Sales & Marketing | Grant or award · Options (right to buy) | +3,000 | $2.80 | $8K | 19,000 |
| 2026-03-18 | Hamm John M. VP Chief Financial Officer | Grant or award · Options (right to buy) | +3,000 | $2.80 | $8K | 18,250 |
| 2026-03-18 | KAZIMI A J Chairman and CEO | Grant or award · Options (right to buy) | +100,000 | $2.80 | $280K | 568,000 |
| 2026-03-16 | KAZIMI A J Chairman and CEO | Shares withheld for taxes | −5,845 | $3.06 | $18K | 5,695,310 |
| 2025-12-31 | Young Caroline Director | Other acquisition 10b5-1 | +5 | $3.91 | $20 | 33,309 |
| 2025-12-31 | Jones James Director | Other acquisition 10b5-1 | +7 | $3.91 | $27 | 45,063 |
| 2025-12-31 | KAZIMI A J Chairman and CEO | Other acquisition 10b5-1 | +7 | $3.91 | $27 | 5,701,155 |
| 2025-12-31 | Krogulski Kenneth Director | Other acquisition 10b5-1 | +62 | $3.91 | $242 | 296,538 |
| 2025-12-30 | Young Caroline Director | Other acquisition 10b5-1 | +2 | $3.94 | $8 | 33,304 |
| 2025-12-30 | Jones James Director | Other acquisition 10b5-1 | +8 | $3.94 | $32 | 45,056 |
| 2025-12-30 | KAZIMI A J Chairman and CEO | Other acquisition 10b5-1 | +8 | $3.94 | $32 | 5,701,148 |
| 2025-12-30 | Krogulski Kenneth Director | Other acquisition 10b5-1 | +54 | $3.94 | $213 | 296,476 |
Page 1 of 201 · 4,006 trades